Gilead reports 3% revenue growth in Q1 2022
New Data On Gilead's Covid-19 Drug Is Positive, but Inconclusive | Barron's
Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back Reimbursement To 340B Providers :: Pink Sheet
Gilead Will Donate Truvada to U.S. for H.I.V. Prevention - The New York Times
Gilead's Hepatitis C Drug, Sovaldi, Is on Pace to Become a Blockbuster - The New York Times
Federal government sues Gilead Sciences, alleging patent infringement on HIV drugs
Gilead Advancing Access®: What to Know | Prism Health North Texas
PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health News : NPR
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour
Gilead Will Begin Marketing Lower Cost Hepatitis C Drugs in January – RWC-340B
Trump administration sues Gilead over HIV drugs
Gilead Sciences, Inc.
Gilead's Biktarvy wins megablockbuster HIV nod, and rival GlaxoSmithKline strikes back | Fierce Pharma
COVID-19 Drug Remdesivir Priced At More Than $3,100 Per Patient : Shots - Health News : NPR
More evidence remdesivir helps some coronavirus patients | CNN
Global shortage of key Covid drug leads to NHS rationing | Coronavirus | The Guardian
Gilead launches combination HIV pill in UK and Germany - PMLiVE
Gilead Revenue Soars on Hepatitis C Drug - The New York Times
Gilead reports reduced mortality risk with remdesivir for Covid-19
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Top Research Reports for JPMorgan, Gilead Sciences & CSX
Generic HIV prevention drug coming in 2020, Gilead says
Gilead's COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged | Fierce Pharma
AHF • AHF Calls on Gilead to Set Up $10 Billion Fund for Victims Harmed by its TDF-based Drugs
A Drug is 90 Percent Effective at Preventing HIV.… | Arnold Ventures
Gilead to Slice List Prices of Liver Drugs - WSJ
Gilead prices remdesivir at $2,340 per patient for developed countries
